When someone first starts treatment with a GLP-1 receptor agonist, we slowly introduce the medication for a reason theres a risk of gastrointestinal side effects as your body gets used to the drug
Additional studies, particularly of GLP-1 RA, GIP and GLP-1 RA, and SGLT2i, will hopefully provide new avenues to reduce mortality in this population, in which there are enormous health disparities
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Antidepressants like Zoloft can cause weight gain or weight loss, depending on the individual
Starting July 1, 2026, Medicare will cover FDA-approved weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) for a flat $50 per month through a new initiative called the Medicare GLP-1 Bridge Program
We keep things simple with transparent pricing, straightforward billing, and affordable generic optionsmaking it easier than ever to take care of yourself